Literature DB >> 11073280

Importance of hyperlipidaemia and therapy in renal patients.

C Wanner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11073280     DOI： 10.1093/ndt/15.suppl_5.92

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Effects of hemodialysis on serum lipids and phospholipids of end-stage renal failure patients.

Authors:  C Piperi; C Kalofoutis; M Tzivras; T Troupis; A Skenderis; A Kalofoutis
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

2.  Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.

Authors:  Holly L Hutton; Adeera Levin; Jagbir Gill; Ognjenka Djurdjev; Mila Tang; Sean J Barbour
Journal:  BMC Nephrol       Date:  2017-03-20       Impact factor: 2.388

3.  Assessment of dyslipidemia in pre-dialysis patients in south-west Nigeria.

Authors:  Effiong Ekong Akpan; Udeme Ekpenyong Ekrikpo; Emmanuel Edet Effa; Aniema Isaac Assam Udo; Solomon Kadiri
Journal:  Niger Med J       Date:  2014-05

4.  Serum lipid profiles, lipid ratios and Chronic Kidney Disease in a Chinese population.

Authors:  Liying Zhang; Zhiyong Yuan; Wu Chen; Shanying Chen; Xinyu Liu; Yan Liang; Xiaofei Shao; Hequn Zou
Journal:  Int J Environ Res Public Health       Date:  2014-07-29       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.